{"name":"Bio Meds Pharmaceutica Ltda","slug":"bio-meds-pharmaceutica-ltda","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Implantable gestrinone","genericName":"Implantable gestrinone","slug":"implantable-gestrinone","indication":"Other","status":"marketed"}]},{"name":"Pain","slug":"pain","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Oral Dienogest","genericName":"Oral Dienogest","slug":"oral-dienogest","indication":"Endometriosis pain management","status":"marketed"}]}],"pipeline":[{"name":"Implantable gestrinone","genericName":"Implantable gestrinone","slug":"implantable-gestrinone","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Oral Dienogest","genericName":"Oral Dienogest","slug":"oral-dienogest","phase":"marketed","mechanism":"Dienogest is a synthetic progestin that suppresses ovulation and alters the endometrium to treat endometriosis.","indications":["Endometriosis pain management"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxPWWlaZFM0RUNNck1yQTBDUnFzSGJKa2hia3BRbjlBRFZJb3NmWE1NM3hid3pmd0hOWURWNlpQTGoyMnJWbWdNa08zRVc5alhTQnhTMzFmcjI3cGpaYnE5NmxXSzJYdHlRd0tLRnhPYmRJbm5FdEJzdld5MDZ3c2ZfR0JyR21PWVRuU2RTZG45azRsYWx4RU5WeVp6YlF4NGNXY0lLVHZPWmVhOHp0RkVCb1BDeXdfN3BY?oc=5","date":"2024-06-12","type":"pipeline","source":"BioSpace","summary":"North America Active Pharmaceutical Ingredients (API) Market Size to Hit USD 146.39 Bn by 2033 - BioSpace","headline":"North America Active Pharmaceutical Ingredients (API) Market Size to Hit USD 146.39 Bn by 2033","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxNaGFRMHFFVlBvMWJDa2x0b1Fzb0FiVTBMVDFWem52YWRIS3V1a0RnUnQ4V0hpU2QtMTdMLTAyOC02LWV5dWd2NzZzNDlMTkhXRmxvazhVMUY4SERoV2E0YmxmNFBhR1J1N3BxNDN2anpSYXVfZlZXQXZYcW9OY2loMTVITDlZeW1GMEpibTg2TmNDaGVYX2ZLNjlqZk1leWR1ekE?oc=5","date":"2024-01-31","type":"deal","source":"Contract Pharma","summary":"Pharmaceutical Industry Mergers & Acquisitions Roundup - Contract Pharma","headline":"Pharmaceutical Industry Mergers & Acquisitions Roundup","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgJBVV95cUxQOGJ5TzJDa2Z0bFhSbW9xT3dJdVJVdmlYUHJmaHpGX2RzUkMwY29ObDFEY2YwYXBhSW53TTFDWmdSZGJvSWNLdUptdWlSbkdyd1F4Sk90Nkdaek1vWmhnZTZQN1I4OWRPcHlGaWhuTFhJUHVDQ0plVFFCNGs4S0lQdWZHTGFJVUdqRG5sRmVla1hNZ1d1NGh3eUM5LVNkQUFZYlpEWGlja3JrTDRxOUdCRldNM3J2VTMwMGM2M3Jzckt2aXNqaUZNYlFhTzVrUFVUS2UweUM1VkdrTkotTUdxQWRxV1J5WFVMN2xza3dYOVNIUTBDcURLNzBBODB2NmlqWTlQVkd6SkpJOWI0aHdTdG9FZ2pHcFJrX3NWZXJfc0pxVmhYT3c?oc=5","date":"2024-01-26","type":"pipeline","source":"BioSpace","summary":"Formosa Pharmaceuticals Announces Licensing Agreement with Cristália, for the Commercialization of APP13007 for the Treatment of Inflammation and Pain Following Ocular Surgery - BioSpace","headline":"Formosa Pharmaceuticals Announces Licensing Agreement with Cristália, for the Commercialization of APP13007 for the Trea","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxOOERHRlpUVWJZQnhXMzRfVmZXMmtGcFJyNG5IS0piTVJkQ0FKS1d1NWJ5ZnotVkNSY1UwQ2x1ZjVlLV9QSXZZSG1mVXNmOGJBbXdPMVlwWXlfQlNpeHhZbG5IRzZPbGdYTldQTHpJakZnbjdqWUszSnh6Q1BXWVhST1phdGhfOFJvN25peTFQUjJQWmRYb1FRR05lV2xxb2RJZXc?oc=5","date":"2021-12-06","type":"trial","source":"globaldata.com","summary":"Contract Small Molecule API Manufacturing Industry by the Numbers – 2021 Edition - globaldata.com","headline":"Contract Small Molecule API Manufacturing Industry by the Numbers – 2021 Edition","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"marketed":2},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}